Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

47.14 -1.56 (-3.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,703,180
Open 48.79
Bid (Size) 47.11 (100)
Ask (Size) 47.25 (400)
Prev. Close 48.70
Today's Range 46.75 - 48.93
52wk Range 22.28 - 59.55
Shares Outstanding 394,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
3 Healthcare Stocks With the Most Durable Competitive Moats ↗
These companies offer a clear path to sustained earnings growth. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+52.8%
+52.8%
1 Month
-2.3%
-2.3%
3 Month
-1.8%
-1.8%
6 Month
+76.8%
+76.8%
1 Year
+71.7%
+71.7%

More News

Read More
News headline image
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Via ACCESS Newswire
News headline image
Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth ↗
Via The Motley Fool
News headline image
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
Via ACCESS Newswire
News headline image
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
Via ACCESS Newswire
News headline image
Moderna to Present at Upcoming Conferences in May 2026
Via ACCESS Newswire
News headline image
What's Pushing Moderna Stock Higher Today? ↗
Via Benzinga
News headline image
Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
Via ACCESS Newswire
News headline image
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Via ACCESS Newswire
News headline image
3 Unpopular Stocks We Approach with Caution
Via StockStory
News headline image
A $2 Trillion IPO and the Space Economy ↗
Via The Motley Fool
Topics Economy Initial Public Offering
News headline image
Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
3 Mid-Cap Stocks We’re Skeptical Of
Via StockStory
News headline image
Looks Like M&A Week in 3 Different Sectors ↗
Via The Motley Fool
News headline image
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
Via ACCESS Newswire
News headline image
2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
Via StockStory
Topics Stocks
News headline image
Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones
Via MarketMinute
Topics Intellectual Property
News headline image
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
News headline image
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
Via Finterra
Topics Initial Public Offering
News headline image
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government Stocks
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth
Via MarketMinute
Topics Artificial Intelligence Economy Stocks

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 47.14
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 04/28/26 04:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 18.57B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.